Verve Therapeutics (VERV)
VERV
Cardiovascular
BiotechSign Signal Grade
F
Signal Grade
10.1/100 composite signal score
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Publications
100
Clinical Activity
8
Pipeline Overview
- Therapeutic Focus
- Cardiovascularsrc
Clinical Trial Activity
3
Clinical Trials
(ClinicalTrials.gov aggregate)
(ClinicalTrials.gov aggregate)
2 Phase 1
Trial Phase Breakdown
5
PubMed Publications
0
Catalyst Records
ClinicalTrials.gov aggregate as of 2026-10-17. ClinicalTrials.gov
Recent News & SEC Filings
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Reduced use of skin testing in the evaluation of antibiotic allergy in the United States. — J Allergy Clin Immunol 2026 Sep 9 PMID 42720632
- Trials and tribulations of spironolactone in heart failure with preserved ejection fraction: Insights from the SPIRIT-HF trial. — Heart Fail Rev 2026 Aug 31 PMID 42671478
- Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data. — Lancet 2026 Sep 19 PMID 42669300
- Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial. — JACC Heart Fail 2026 Aug 30 PMID 42669075
- Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial. — Circulation 2026 Sep 15 PMID 42610264
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Verve Therapeutics.
Full VERV Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.